Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.

Source:http://linkedlifedata.com/resource/pubmed/id/19789349

Cancer Res. 2009 Oct 1 69 19 7644-52

Download in:

View as

General Info

PMID
19789349